BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 820173)

  • 1. Enzyme replacement therapy for the sphingolipidoses.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Quirk JM; Mook GE; Kusiak JW; Tallman JF; Dekaban AS
    Adv Exp Med Biol; 1976; 68():523-32. PubMed ID: 820173
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations in enzyme replacement therapy in lipid storage diseases.
    Brady RO; Pentchev PG; Gal AG
    Fed Proc; 1975 Apr; 34(5):1310-5. PubMed ID: 804420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement therapy in Gaucher's and Fabry's disease.
    Pentchev PG
    Ann Clin Lab Sci; 1977; 7(3):251-3. PubMed ID: 404951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and novel treatments for sphingolipidoses.
    Arenz C
    Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of sphingolipidosis with accumulation of various lipids in different organs and multiple enzymatic changes in the liver].
    Giardini O; Cardi E; Castro M; Cao M
    Minerva Pediatr; 1975 Dec; 27(39):2188-94. PubMed ID: 172772
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic and therapeutic applications of sphingolipid hydrolyzing enzymes.
    Brady RO
    Curr Top Cell Regul; 1985; 26():39-50. PubMed ID: 3935381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sphingolipidoses. Biochemistry and enzymatic mechanisms].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(26):1789-92. PubMed ID: 5054020
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical approaches to the nosology of nervous system defects, II.
    Brady RO
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):33-6. PubMed ID: 4376033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sphingolipidosis].
    Lutz W
    Pol Tyg Lek; 1980 Dec; 35(52):2067-71. PubMed ID: 6794014
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymic diagnosis of sphingolipidoses.
    Suzuki K
    Methods Enzymol; 1978; 50():456-88. PubMed ID: 26837
    [No Abstract]   [Full Text] [Related]  

  • 11. Haematological aspects of lipid storage diseases.
    Brady RO
    Acta Haematol Pol; 1977; 8(2):103-12. PubMed ID: 407769
    [No Abstract]   [Full Text] [Related]  

  • 12. The lipid storage diseases: new concepts and control.
    Brady RO
    Ann Intern Med; 1975 Feb; 82(2):257-61. PubMed ID: 163609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent observations on Gaucher's disease.
    Kanfer JN; Raghaven SS; Mumford RA; Sullivan J; Spielvogel ; legler G; Labow RS; Williamson DG; Layne DS
    Adv Exp Med Biol; 1976; 68():77-98. PubMed ID: 937123
    [No Abstract]   [Full Text] [Related]  

  • 14. Normalization of liver glucosylceramide levels in the "Gaucher" mouse by phosphatidylserine injection.
    Datta SC; Radin NS
    Biochem Biophys Res Commun; 1988 Apr; 152(1):155-60. PubMed ID: 3358758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic errors and enzyme replacement strategies.
    Brady RO
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():181-93. PubMed ID: 6130585
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disturbances of the lipid metabolism in relation to the nervous system. II. Sphingolipids and sphingolipidoses].
    Tichý J
    Cesk Neurol; 1973 Jan; 36(1):51-60. PubMed ID: 4685128
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme replacement therapy in type I Gaucher disease.
    Kay AC; Saven A; Garver P; Thurston DW; Rosenbloom BF; Beutler E
    Trans Assoc Am Physicians; 1991; 104():258-64. PubMed ID: 1845151
    [No Abstract]   [Full Text] [Related]  

  • 18. The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable.
    Berger J; Stirnemann J; Bourgne C; Pereira B; Pigeon P; Heraoui D; Froissart R; Rapatel C; Rose C; Belmatoug N; Berger MG
    Br J Haematol; 2012 Apr; 157(2):274-7. PubMed ID: 22224474
    [No Abstract]   [Full Text] [Related]  

  • 19. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
    N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
    [No Abstract]   [Full Text] [Related]  

  • 20. Further developments in studies in sphingolipidoses: "missing enzymes".
    Brady RO
    Riv Patol Nerv Ment; 1970 Oct; 91(5):263-73. PubMed ID: 5525771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.